Apply for funding Active research projects Ex Vivo Human Liver Hyperfusion Model Understanding the effects of increased blood flow and regeneration on human livers A2002397 Liver failure following extensive liver cancer resection or partial liver transplantation is a significant complication. After such major operations, it is essential for the remnant liver or the transplanted partial liver to be in good health to sustain its numerous functions until the liver regenerates, a phenomenon unique to this organ. The higher blood flow (hyperperfusion) through these small livers can cause substantial damage, leading to liver failure and, unfortunately, patient death in most instances. In this pioneering research, Dr. Shaili Patel at the Leeds Institute of Cardiovascular and Metabolic Medicine (LICAMM), University of Leeds, in collaboration with Leeds Teaching Hospitals NHS Trust, aims to build a machine perfusion model (ex vivo; “out of the living”) to study the intricate mechanisms of human liver injury induced by higher blood flow. This approach will allow the investigation of the mechanisms underlying liver regeneration and failure in a laboratory-simulated setting and identify targeted therapies to overcome this fatal complication. As a prominent clinical centre specialising in liver diseases, the mission is to improve outcomes in patients, particularly those with fatty liver and cancer. This study is an important step towards this paramount goal. Leeds Teaching Hospitals NHS Trust (LTHT) is the lead centre for Living Donor Liver Transplant (LDLT), and this pivotal project will help establish LTHT as the Centre of Excellence for LDLT and Liver Cancer Surgery. Lead Researcher Ms Shaili Krishnakant PatelResearch Fellow in HPD and Transplant SurgerySenior Registrar in General Surgery Co-Researchers Mr Raj Prasad Mr Abdul Hakeem Prof David Beech Dr Laeticia Lichtenstein Mr Charalampos Konstantinou Prof Tze Min Wah Host Organisation/CSU Abdominal Medicine and Surgery Leeds Teaching Hospitals NHS Trust University of Leeds Grant Amount £239,815.87 Start Date 05/10/2023 Estimated Duration 35 months Impact Areas Health Inequalities – Cancer Care Health Inequalities Paediatric Care Innovation and Health technologies Tags/key notes Early Career Researcher Cancer and neoplasms Manage Cookie Preferences